194 related articles for article (PubMed ID: 35463337)
21. Bronchoprotective effects of leukotriene receptor antagonists in asthma: a meta-analysis.
Currie GP; Lipworth BJ
Chest; 2002 Jul; 122(1):146-50. PubMed ID: 12114350
[TBL] [Abstract][Full Text] [Related]
22. Pharmacodynamic properties of leukotriene receptor antagonists.
Nicosia S
Monaldi Arch Chest Dis; 1999 Jun; 54(3):242-6. PubMed ID: 10441979
[TBL] [Abstract][Full Text] [Related]
23. Targeting the Leukotriene Pathway for Colon Cancer Interception.
Mohammed A; Shoemaker RH
Cancer Prev Res (Phila); 2022 Oct; 15(10):637-640. PubMed ID: 36193659
[TBL] [Abstract][Full Text] [Related]
24. Influence of weight status in the response to Step-2 maintenance therapies in children with asthma.
Longo C; Bartlett G; Schuster T; Ducharme FM; MacGibbon B; Barnett TA
BMJ Open Respir Res; 2019; 6(1):e000401. PubMed ID: 31179003
[TBL] [Abstract][Full Text] [Related]
25. Leukotriene Receptor Antagonists and Antiallergy Drugs.
Tamada T; Ichinose M
Handb Exp Pharmacol; 2017; 237():153-169. PubMed ID: 27826703
[TBL] [Abstract][Full Text] [Related]
26. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children.
Watts K; Chavasse RJ
Cochrane Database Syst Rev; 2012 May; 2012(5):CD006100. PubMed ID: 22592708
[TBL] [Abstract][Full Text] [Related]
27. Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids.
Wu AC; Li L; Fung V; Kharbanda EO; Larkin EK; Vollmer WM; Butler MG; Miroshnik I; Rusinak D; Davis RL; Hartert T; Weiss ST; Lieu TA
J Allergy Clin Immunol Pract; 2014; 2(5):607-13. PubMed ID: 25213056
[TBL] [Abstract][Full Text] [Related]
28. Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children.
Brodlie M; Gupta A; Rodriguez-Martinez CE; Castro-Rodriguez JA; Ducharme FM; McKean MC
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008202. PubMed ID: 26482324
[TBL] [Abstract][Full Text] [Related]
29. Risk of Neuropsychiatric Diseases According to the Use of a Leukotriene Receptor Antagonist in Middle-Aged and Older Adults with Asthma: A Nationwide Population-Based Study Using Health Claims Data in Korea.
Shim JS; Kim MH; Kim MH; Cho YJ; Chun EM
J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4290-4297. PubMed ID: 34166842
[TBL] [Abstract][Full Text] [Related]
30. Safety of leukotriene receptor antagonists in pregnancy.
Bakhireva LN; Jones KL; Schatz M; Klonoff-Cohen HS; Johnson D; Slymen DJ; Chambers CD;
J Allergy Clin Immunol; 2007 Mar; 119(3):618-25. PubMed ID: 17336611
[TBL] [Abstract][Full Text] [Related]
31. A comparison of tiotropium, long-acting β
Vogelberg C; Goldstein S; Graham L; Kaplan A; de la Hoz A; Hamelmann E
Respir Res; 2020 Jan; 21(1):19. PubMed ID: 31931792
[TBL] [Abstract][Full Text] [Related]
32. The protective effects of leukotriene modifiers in aspirin-induced asthma.
Israel E
Postgrad Med; 2000 Sep; 108(4 Suppl):40-4. PubMed ID: 19667532
[TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of leukotriene receptor antagonists in preventing common cold-like symptoms in bronchial asthma patients.
Horiguchi T; Ohira D; Kobayashi K; Hirose M; Miyazaki J; Kondo R; Tachikawa S
Allergol Int; 2007 Sep; 56(3):263-7. PubMed ID: 17582209
[TBL] [Abstract][Full Text] [Related]
34. Pharmacology of leukotriene receptor antagonists. More than inhibitors of bronchoconstriction.
Hay DW
Chest; 1997 Feb; 111(2 Suppl):35S-45S. PubMed ID: 9042025
[TBL] [Abstract][Full Text] [Related]
35. Leukotriene receptor antagonists pranlukast and montelukast for treating asthma.
Matsuse H; Kohno S
Expert Opin Pharmacother; 2014 Feb; 15(3):353-63. PubMed ID: 24350802
[TBL] [Abstract][Full Text] [Related]
36. The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.
Hoxha M; Rovati GE; Cavanillas AB
Eur J Clin Pharmacol; 2017 Jul; 73(7):799-809. PubMed ID: 28374082
[TBL] [Abstract][Full Text] [Related]
37. Oral Antihistamines Alone vs in Combination with Leukotriene Receptor Antagonists for Allergic Rhinitis: A Meta-analysis.
Liu G; Zhou X; Chen J; Liu F
Otolaryngol Head Neck Surg; 2018 Mar; 158(3):450-458. PubMed ID: 29337654
[TBL] [Abstract][Full Text] [Related]
38. Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial.
Wilson EC; Price D; Musgrave SD; Sims EJ; Shepstone L; Murdoch J; Mugford HM; Blyth A; Juniper EF; Ayres JG; Wolfe S; Freeman D; Gilbert RF; Hillyer EV; Harvey I
Pharmacoeconomics; 2010; 28(7):597-608. PubMed ID: 20446755
[TBL] [Abstract][Full Text] [Related]
39. Comparison of leukotriene receptor antagonists and anti-histamines as an add-on therapy in patients with asthma complicated by allergic rhinitis.
Nishimura M; Koga T; Kamimura T; Sato R; Natori H; Matsuo K; Aizawa H
Kurume Med J; 2011; 58(1):9-14. PubMed ID: 22027192
[TBL] [Abstract][Full Text] [Related]
40. Addition of antileukotriene agents to inhaled corticosteroids in children with persistent asthma.
Chong JK; Chauhan BF
Paediatr Child Health; 2014 Nov; 19(9):473-4. PubMed ID: 25414582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
